Table 3 Nutrient Consumption between Supplement Trials
From: Acute effects of Nitrosigine® and citrulline malate on vasodilation in young adults
Supplement | ANOVA (Nutrient (1) x Supplement (3)) | ||
|---|---|---|---|
Total Energy (kcal) | Citrulline Malate | 2615.30 ± 1105.40 | F = 2.00, p = .15 |
Nitrosigine® | 3103.00 ± 1310.64 | ||
Placebo | 2921.27 ± 1402.11 | ||
Protein (g) | Citrulline Malate | 133.85 ± 47.78 | F = 0.34, p = .71 |
Nitrosigine® | 139.82 ± 49.93 | ||
Placebo | 142.94 ± 54.97 | ||
Carbohydrate (g) | Citrulline Malate | 283.84 ± 163.51 | F = 3.33, p = .047 |
Nitrosigine® | 376.47 ± 196.54 | ||
Placebo | 328.22 ± 184.43 | ||
Total Fat (g) | Citrulline Malate | 107.49 ± 47.12 | F = 0.98, p = .39 |
Nitrosigine® | 120.05 ± 51.98 | ||
Placebo | 118.48 ± 62.34 |